Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis (Dermatology and Therapy, (2024), 14, 1, (169-182), 10.1007/s13555-023-01058-z)
- Rand, K.
- Ramos-Goñi, J.M.
- Akmaz, B.
- Solé-Feu, L.
- Armario-Hita, J.-C.
ISSN: 2190-9172, 2193-8210
Ano de publicación: 2024
Volume: 14
Número: 1
Páxinas: 183-185
Tipo: Errata